by Mednet | Feb 17, 2022 | Blog
Numerous factors are changing the way clinical trials are conducted. Increasingly complex trial designs, global patient groups, and decentralized trial models have significantly impacted how trial information is tracked and managed. These factors have also influenced...
by Mednet | Jan 26, 2022 | Blog
SCOPE Summit 2022 in Orlando, FL is less than two weeks away, and the Mednet team is looking forward to exhibiting in person for the first time in two years! If you are attending in person, we hope you will stop by our booth for a bit of fun and to learn more about...
by Mednet | Jan 13, 2022 | Blog
Saying hello to a new year has got us thinking about what’s in store for the clinical research industry in 2022. In the past two years, we have seen quick and substantial pivots in the way clinical trials are conducted. Every aspect of a trial has been reshaped,...
by Mednet | Dec 2, 2021 | Blog
Adaptive trial designs emerged as a means to improve clinical trials based on all available information. High failure rates and increasing costs have driven the industry toward adaptive trial designs. In The Adaptive Designs for Clinical Trials of Drugs and Biologics...
by Mednet | Nov 11, 2021 | Blog
Introduction Real-Word Data (RWD) and Real-World Evidence (RWE) are acronyms that have been thrown around the industry for some time. As healthcare, life sciences companies and regulators look at the potential research opportunities that...
by Mednet | Oct 26, 2021 | Blog
October is Breast Cancer Awareness Month. The National Breast Cancer Foundation estimates one in eight women in the United States will be diagnosed with breast cancer in her lifetime.1 Most of us know a friend or family member who has faced a diagnosis of breast...
